Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-trace').style.display = (document.getElementById('cakeErr67f984a021d1c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f984a021d1c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-code').style.display = (document.getElementById('cakeErr67f984a021d1c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-context').style.display = (document.getElementById('cakeErr67f984a021d1c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f984a021d1c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f984a021d1c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6295,
		&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6389,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6295,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6295,
	&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6389,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6295
$metaTitle = &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="

&lsquo;It will hinder access to quality, affordable generic medicines produced in India' 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br /><br />People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br /><br />The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br /><br />Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br /><br />Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br /><br />World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br /><br />Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br /><br />&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br /><br />&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br /><br /><em>Most damaging clause<br /></em><br />The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br /><br />The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br /><br />The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br /><br />Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-trace').style.display = (document.getElementById('cakeErr67f984a021d1c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f984a021d1c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-code').style.display = (document.getElementById('cakeErr67f984a021d1c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-context').style.display = (document.getElementById('cakeErr67f984a021d1c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f984a021d1c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f984a021d1c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6295,
		&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6389,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6295,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6295,
	&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6389,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6295
$metaTitle = &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="

&lsquo;It will hinder access to quality, affordable generic medicines produced in India' 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br /><br />People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br /><br />The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br /><br />Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br /><br />Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br /><br />World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br /><br />Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br /><br />&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br /><br />&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br /><br /><em>Most damaging clause<br /></em><br />The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br /><br />The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br /><br />The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br /><br />Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-trace').style.display = (document.getElementById('cakeErr67f984a021d1c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f984a021d1c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-code').style.display = (document.getElementById('cakeErr67f984a021d1c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f984a021d1c-context').style.display = (document.getElementById('cakeErr67f984a021d1c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f984a021d1c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f984a021d1c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6295,
		&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6389,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6295,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6295,
	&#039;title&#039; =&gt; &#039;HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;
&lt;br /&gt;
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;
&lt;br /&gt;
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;
&lt;br /&gt;
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;
&lt;br /&gt;
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;
&lt;br /&gt;
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Most damaging clause&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;
&lt;br /&gt;
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;
&lt;br /&gt;
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;
&lt;br /&gt;
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6389,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6295
$metaTitle = &#039;LATEST NEWS UPDATES | HIV patients say ‘no&#039; to IP provision on generic drugs by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;

&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;&amp;lsquo;It will hinder access to quality, affordable generic medicines produced in India&#039; &lt;br /&gt;&lt;br /&gt;People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &amp;ldquo;pharmacy of the developing world,&amp;rdquo; they pointed out here on Wednesday.&lt;br /&gt;&lt;br /&gt;Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.&lt;br /&gt;&lt;br /&gt;Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.&lt;br /&gt;&lt;br /&gt;World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.&lt;br /&gt;&lt;br /&gt;Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We rely on affordable medicines made here in India to stay alive,&amp;rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We don&#039;t want to go back in time when our friends and loved ones died just because they couldn&#039;t afford the medicines. Don&#039;t trade away our lives in the EU-India FTA,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Most damaging clause&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &amp;lsquo;data exclusivity,&#039; which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India&#039;s strict patent law.&lt;br /&gt;&lt;br /&gt;The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.&lt;br /&gt;&lt;br /&gt;The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.&lt;br /&gt;&lt;br /&gt;Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="

&lsquo;It will hinder access to quality, affordable generic medicines produced in India' 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br /><br />People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br /><br />The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br /><br />Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br /><br />Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br /><br />World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br /><br />Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br /><br />&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br /><br />&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br /><br /><em>Most damaging clause<br /></em><br />The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br /><br />The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br /><br />The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br /><br />Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 6295,
		'title' => 'HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar',
		'subheading' => '',
		'description' => '<br />
<div align="justify">
&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br />
<br />
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br />
<br />
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br />
<br />
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br />
<br />
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br />
<br />
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br />
<br />
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br />
<br />
&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br />
<br />
&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br />
<br />
<em>Most damaging clause<br />
</em><br />
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br />
<br />
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br />
<br />
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br />
<br />
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br />
<br />
</div>',
		'credit_writer' => 'The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 6389,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 6295,
	'metaTitle' => 'LATEST NEWS UPDATES | HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar',
	'metaKeywords' => 'Health',
	'metaDesc' => '

&lsquo;It will hinder access to quality, affordable generic medicines produced in India' 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...',
	'disp' => '<br /><div align="justify">&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br /><br />People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br /><br />The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br /><br />Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br /><br />Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br /><br />World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br /><br />Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br /><br />&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br /><br />&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br /><br /><em>Most damaging clause<br /></em><br />The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br /><br />The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br /><br />The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br /><br />Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br /><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 6295,
	'title' => 'HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar',
	'subheading' => '',
	'description' => '<br />
<div align="justify">
&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br />
<br />
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br />
<br />
The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br />
<br />
Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br />
<br />
Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br />
<br />
World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br />
<br />
Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br />
<br />
&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br />
<br />
&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br />
<br />
<em>Most damaging clause<br />
</em><br />
The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br />
<br />
The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br />
<br />
The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br />
<br />
Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br />
<br />
</div>',
	'credit_writer' => 'The Hindu, 3 March, 2011, http://www.hindu.com/2011/03/03/stories/2011030364321500.htm',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'hiv-patients-say-no-to-ip-provision-on-generic-drugs-by-aarti-dhar-6389',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 6389,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 6295
$metaTitle = 'LATEST NEWS UPDATES | HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar'
$metaKeywords = 'Health'
$metaDesc = '

&lsquo;It will hinder access to quality, affordable generic medicines produced in India' 

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European...'
$disp = '<br /><div align="justify">&lsquo;It will hinder access to quality, affordable generic medicines produced in India' <br /><br />People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.<br /><br />The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the &ldquo;pharmacy of the developing world,&rdquo; they pointed out here on Wednesday.<br /><br />Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America.<br /><br />Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines.<br /><br />World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said.<br /><br />Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives.<br /><br />&ldquo;We rely on affordable medicines made here in India to stay alive,&rdquo; said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People.<br /><br />&ldquo;We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,&rdquo; he said.<br /><br /><em>Most damaging clause<br /></em><br />The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called &lsquo;data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law.<br /><br />The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged.<br /><br />The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future.<br /><br />Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.<br /><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar

‘It will hinder access to quality, affordable generic medicines produced in India' People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations. The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the “pharmacy of the developing world,” they pointed out here on Wednesday. Affordable medicines produced in India have played a major role in scaling up AIDS treatment to more than five million people across Asia, Africa and Latin America. Hundreds of people living with HIV from different parts of India and Asia marched to the office of the United Nations Special Rapporteur on Right to Health in New Delhi to highlight the grave danger this FTA brings to countless human lives in developing countries by preventing the production, registration and distribution of quality, affordable generic medicines. World Trade Organization rules already obligated India to grant medicines patents in 2005, which is preventing production and access to affordable versions of Hepatitis C drugs and the new generation of cancer and HIV/AIDS medicines, some of which have already been patented in India, the patients said. Sharing their concerns at a press conference following the rally, the patient groups said there would be an adverse impact of trade agreements on their lives. “We rely on affordable medicines made here in India to stay alive,” said Nepal-based Rajiv Kafle of the Asia Pacific Network of Positive People. “We don't want to go back in time when our friends and loved ones died just because they couldn't afford the medicines. Don't trade away our lives in the EU-India FTA,” he said. Most damaging clause The EU is pushing for IP provisions in the FTA that exceed what international trade rules require. The most damaging clause that will hinder access to affordable medicines is the so-called ‘data exclusivity,' which would act like a patent and block generic versions from the market, even for drugs that are already off patent, or do not merit a patent to begin with under India's strict patent law. The EU continues to falsely claim that these provisions will not harm access to medicines, the patients alleged. The IP provisions the EU is pushing would make this difficult situation significantly worse, by imposing even more restrictions on the production of affordable generic medicines in the future. Intellectual property in FTAs can undermine the right to health in many ways. For instance, tobacco companies are using FTAs with intellectual property in investment chapters to sue governments directly for their efforts to bring in measures to protect public health, they alleged.